156 related articles for article (PubMed ID: 9889028)
1. Phase I trial of concomitant chemoradiotherapy for cervical cancer and other advanced pelvic malignancies.
Mundt AJ; Rotmensch J; Waggoner S; Quiet C; Fleming G
Gynecol Oncol; 1999 Jan; 72(1):45-50. PubMed ID: 9889028
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies.
Mundt AJ; Rotmensch J; Waggoner SE; Yamada D; Langhauser C; Fleming GF
Gynecol Oncol; 2001 Aug; 82(2):333-7. PubMed ID: 11531289
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
Stehman FB; Bundy BN; Kucera PR; Deppe G; Reddy S; O'Connor DM
Gynecol Oncol; 1997 Aug; 66(2):262-7. PubMed ID: 9264574
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of concomitant vinorelbine, cisplatin, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies.
Mundt AJ; Rotmensch J; Waggoner SE; Yamada SD; Fleming GF
Gynecol Oncol; 2004 Mar; 92(3):801-5. PubMed ID: 14984944
[TBL] [Abstract][Full Text] [Related]
5. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
6. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.
Jurado M; Martínez-Monge R; García-Foncillas J; Azinovic I; Aristu J; López-García G; Brugarolas A
Gynecol Oncol; 1999 Jul; 74(1):30-7. PubMed ID: 10385548
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Lanciano R; Calkins A; Bundy BN; Parham G; Lucci JA; Moore DH; Monk BJ; O'Connor DM
J Clin Oncol; 2005 Nov; 23(33):8289-95. PubMed ID: 16230678
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of taxol as a radiation sensitizer with cisplatin in advanced cervical cancer.
Chen MD; Paley PJ; Potish RA; Twiggs LB
Gynecol Oncol; 1997 Nov; 67(2):131-6. PubMed ID: 9367695
[TBL] [Abstract][Full Text] [Related]
9. Hyperfractionated radiation therapy plus chemotherapy in locally advanced cervical cancer: results of two phase I dose-escalation Gynecologic Oncology Group trials.
Calkins AR; Harrison CR; Fowler WC; Gallion H; Mangan CE; Husseinzadeh N; Alvarez RD; Mychalczak B; Podczaski E
Gynecol Oncol; 1999 Dec; 75(3):349-55. PubMed ID: 10600288
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.
Vokes EE; Haraf DJ; Brockstein BE; Weichselbaum RR
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):70-6. PubMed ID: 10210543
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
[TBL] [Abstract][Full Text] [Related]
12. Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer.
Spencer S; Wheeler R; Peters G; Meredith R; Beenken S; Nabel L; Wooten A; Soong SJ; Salter M
Head Neck; 2003 Feb; 25(2):118-22. PubMed ID: 12509794
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma.
Windschall A; Ott OJ; Sauer R; Strnad V
Strahlenther Onkol; 2005 Aug; 181(8):545-50. PubMed ID: 16044224
[TBL] [Abstract][Full Text] [Related]
14. Concurrent chemotherapy and hypofractionated twice-daily radiotherapy in cervical cancer patients with stage IIIB disease and bilateral parametrial involvement: a phase I-II study.
Viegas CM; Araujo CM; Dantas MA; Froimtchuk M; Oliveira JA; Marchiori E; Souhami L
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1154-9. PubMed ID: 15519787
[TBL] [Abstract][Full Text] [Related]
15. Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study.
Cellini N; Smaniotto D; Scambia G; Luzi S; Balducci M; Ferrandina G; Corvari B; Margariti PA; Valentini V; D'Agostino G
Am J Clin Oncol; 2008 Jun; 31(3):280-4. PubMed ID: 18525308
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancer.
Parulekar W; de Marsh RW; Wong R; Mendenhall W; Davey P; Zlotecki R; Berry S; Rout WR; Bjarnason GA
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1487-95. PubMed ID: 15050328
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancer.
Tsujie M; Nakamori S; Tanaka E; Nagano H; Umeshita K; Dono K; Sakon M; Inoue T; Inoue T; Monden M
Jpn J Clin Oncol; 2006 Aug; 36(8):504-10. PubMed ID: 16855011
[TBL] [Abstract][Full Text] [Related]
18. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
Serkies K; Jassem J
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
[TBL] [Abstract][Full Text] [Related]
19. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
[TBL] [Abstract][Full Text] [Related]
20. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Katori H; Tsukuda M; Taguchi T
Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]